Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live11-20

Health care stocks fell late Wednesday afternoon with the NYSE Health Care Index easing 0.1% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.2%.

The iShares Biotechnology ETF (IBB) shed 0.7%.

In corporate news, Pfizer (PFE) and its supplier Tris Pharma reached a $41.5 million settlement with Texas Attorney General Ken Paxton for allegedly providing adulterated attention deficit hyperactivity disorder medication to children. Pfizer shares dropped 2%.

Johnson & Johnson's (JNJ) Janssen Biotech unit has been granted traditional approval for Darzalex Faspro with bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed light chain amyloidosis, the US Food and Drug Administration said. Johnson & Johnson shares rose 1.4%.

Moderna (MRNA) is onshoring drug product manufacturing to its Moderna Technology Center in Norwood, Massachusetts. The company said the move boosts its US commercial and clinical supply capabilities, and reflects more than $140 million in planned investment. The stock dropped 3%.

Agios Pharmaceuticals (AGIO) shares tumbled 51% after the company said its potential sickle cell disease treatment mitapivat failed to meet one of two primary endpoints in a 52-week Phase 3 trial.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment